INBIOS INTERNATIONAL INC
- SEATTLE, WA 98109
- inbios.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM expiring
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $49.7M
- Awards on record
- 9
- Contract vehicles
- 0
- Verified credentials
- 0
SAM.gov registration expires in 27 days
INBIOS INTERNATIONAL INC’s registration expires on Dec 10, 2026. Renewal can take weeks; confirm it stays active through proposal submission and award.
View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI
About INBIOS INTERNATIONAL INC
- Headquarters
- SEATTLE, WA 98109
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEICNJNQ1GMSN55
- CAGE3KJL6
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $49.7M
- Awards on record
- 9
- Top funding agencies
- Office of Assistant Secretary for Preparedness and Response · Defense Health Agency · National Institutes of Health
Awards
HHSO100201700029C
Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)IGF::OT::IGF - BASE PERIOD AWARD TO INBIOS INTERNATIONAL, INC. FOR POINT-OF-CARE IMMUNOASSAY FOR DIAGNOSIS OF INHALATIONAL ANTHRAX
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $4M
- Period of performance
- Sep 26, 2017 – Sep 30, 2027
75D30126P20991
Completed: Period of performance ended Sep 19, 2026INBIOS REAGENTS KITS
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $62.3K
- Period of performance
- Apr 20, 2026 – Sep 19, 2026
75N91024C00078
Completed: Period of performance ended Sep 15, 2025TOPIC 455: DEVELOPMENT OF A RAPID AT-HOME TEST TO DETECT PROSTATE-SPECIFIC ANTIGEN USING SELF-COLLECTED FINGER STICKBLOOD
Department of Health and Human Services · National Institutes of Health
- Obligated
- $399.9K
- Period of performance
- Sep 16, 2024 – Sep 15, 2025
W81XWH20F0253
Completed: Period of performance ended May 31, 2025COVID-19-FDA EUA ANTIGEN DETECTION- FDA FAST TRACK SEROLOGY ASSAY OPTIMIZATION
Department of Defense · Defense Health Agency
- Obligated
- $24.5M
- Period of performance
- Jun 15, 2020 – May 31, 2025
75A50223C00041
Completed: Period of performance ended Mar 19, 2025OVER THE COUNTER (OTC) COVID-19 TESTS
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Obligated
- $20.7M
- Period of performance
- Sep 20, 2023 – Mar 19, 2025
SPE2DS24P1185
Completed: Period of performance ended Jun 24, 20248510704349!TEST KIT,VISCERAL L
Department of Defense · Defense Logistics Agency
- Obligated
- $4.7K
- Period of performance
- Jun 18, 2024 – Jun 24, 2024
SPE2DS24P1075
Completed: Period of performance ended Jun 4, 20248510632304!TEST KIT,VISCERAL L
Department of Defense · Defense Logistics Agency
- Obligated
- $856
- Period of performance
- May 15, 2024 – Jun 4, 2024
75D30123P17663
Completed: Period of performance ended Sep 28, 2023INBIOS SUPPLIES & REAGENTS
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $18.8K
- Period of performance
- Aug 24, 2023 – Sep 28, 2023
75D30119P05402
Completed: Period of performance ended Sep 24, 2019INBIOS INTERNATIONAL, INC DETECT IGM CAPTURE ELISA KIT AND ACCESSORIES
Department of Health and Human Services · Centers for Disease Control and Prevention
- Obligated
- $61.5K
- Period of performance
- Jun 7, 2019 – Sep 24, 2019
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
HHSO100201700029C IGF::OT::IGF - BASE PERIOD AWARD TO INBIOS INTERNATIONAL, INC. FOR POINT-OF-CARE IMMUNOASSAY FOR DIAGNOSIS OF INHALATIONAL ANTHRAX | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 541711 · AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $4M | Sep 26, 2017 – Sep 30, 2027 | Recompete 6–12 mo: Potential end Sep 30, 2027 (10 months away)AI brief for award HHSO100201700029CBid team for the recompete of award HHSO100201700029C |
75D30126P20991 INBIOS REAGENTS KITS | Department of Health and Human Services · Centers for Disease Control and Prevention | 325413 · 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $62.3K | Apr 20, 2026 – Sep 19, 2026 | Completed: Period of performance ended Sep 19, 2026 |
75N91024C00078 TOPIC 455: DEVELOPMENT OF A RAPID AT-HOME TEST TO DETECT PROSTATE-SPECIFIC ANTIGEN USING SELF-COLLECTED FINGER STICKBLOOD | Department of Health and Human Services · National Institutes of Health | 541714 · AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $399.9K | Sep 16, 2024 – Sep 15, 2025 | Completed: Period of performance ended Sep 15, 2025 |
W81XWH20F0253 under W81XWH16D0009 COVID-19-FDA EUA ANTIGEN DETECTION- FDA FAST TRACK SEROLOGY ASSAY OPTIMIZATION | Department of Defense · Defense Health Agency | 541711 · AJ53R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (ADVANCED DEVELOPMENT) | $24.5M | Jun 15, 2020 – May 31, 2025 | Completed: Period of performance ended May 31, 2025 |
75A50223C00041 OVER THE COUNTER (OTC) COVID-19 TESTS | Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response | 325413 · 6650OPTICAL INSTRUMENTS, TEST EQUIPMENT, COMPONENTS AND ACCESSORIES | $20.7M | Sep 20, 2023 – Mar 19, 2025 | Completed: Period of performance ended Mar 19, 2025 |
SPE2DS24P1185 8510704349!TEST KIT,VISCERAL L | Department of Defense · Defense Logistics Agency | 621410 · 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $4.7K | Jun 18, 2024 – Jun 24, 2024 | Completed: Period of performance ended Jun 24, 2024 |
SPE2DS24P1075 8510632304!TEST KIT,VISCERAL L | Department of Defense · Defense Logistics Agency | 621410 · 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $856 | May 15, 2024 – Jun 4, 2024 | Completed: Period of performance ended Jun 4, 2024 |
75D30123P17663 INBIOS SUPPLIES & REAGENTS | Department of Health and Human Services · Centers for Disease Control and Prevention | 325413 · 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $18.8K | Aug 24, 2023 – Sep 28, 2023 | Completed: Period of performance ended Sep 28, 2023 |
75D30119P05402 INBIOS INTERNATIONAL, INC DETECT IGM CAPTURE ELISA KIT AND ACCESSORIES | Department of Health and Human Services · Centers for Disease Control and Prevention | 325413 · 6640LABORATORY EQUIPMENT AND SUPPLIES | $61.5K | Jun 7, 2019 – Sep 24, 2019 | Completed: Period of performance ended Sep 24, 2019 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 41 awards
- Total awarded
- $19,803,213
- By phase
- SBIR Phase I: 24
- SBIR Phase II: 13
- STTR Phase I: 3
- STTR Phase II: 1
- By agency
- Department of Health and Human Services: 20
- Department of Defense: 19
- Department of Agriculture: 2
- Active projects
- 1 project
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 1 project
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2024: 2
- 2021: 1
- 2020: 2
- 2016: 1
- 2015: 1
- 2014: 1
- 2012: 3
- 2010: 4
- 2009: 4
- 2008: 3
- 2007: 4
- 2006: 5
- 2005: 4
- 2004: 1
- 2002: 1
- 2001: 2
- 2000: 2
Awards (most recent first)
Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2024 · $1,988,974
May 8, 2024 – Apr 30, 2027
- Active
- Ends Apr 2027
Solicitation PA23-230 (2023) · Topic NIAID
TOPIC 455: DEVELOPMENT OF A RAPID AT-HOME TEST TO DETECT PROSTATE-SPECIFIC ANTIGEN USING SELF-COLLECTED FINGER STICKBLOOD
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $399,866
Solicitation PHS-2024-1 (2024) · Topic 455
DEVELOPMENT OF NEXT-GEN CHAGAS DETECTTM PLUS RAPID TEST FOR SENSITIVE AND SPECIFIC DIAGNOSIS OF CHAGAS
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $299,584
Solicitation PHS2021-1 (2020) · Topic 96
Diagnostic Device for Norovirus Gastroenteritis
SBIR Phase II · Department of Defense (Army) · 2020 · $961,577
Mar 12, 2020 – Jan 22, 2023
Solicitation 14.1 (2014) · Topic A14-049
Point-of-care antigen detection assay for early diagnosis of Ebola virus disease (EVD)
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $598,047
Mar 10, 2020 – Feb 28, 2022
Solicitation PA18-575 (2018) · Topic NIAID · Research partner: UNIVERSITY OF NEVADA RENO
Diagnostic Device for Norovirus Gastroenteritis
SBIR Phase II · Department of Defense (Army) · 2016 · $891,868
Nov 13, 2015 – Jan 14, 2020
Solicitation 14.1 (2014) · Topic A14-049
Diagnostic Device for Norovirus Gastroenteritis
SBIR Phase I · Department of Defense (Army) · 2015 · $149,075
Nov 10, 2014 – Jul 31, 2016
Solicitation 2014.1 (2014) · Topic A14-049
Antigen Detection assay for the Diagnosis of Melioidosis
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2014 · $1,994,739
Jul 1, 2014 – Jun 30, 2019
Solicitation PA10-124 (2010) · Topic NIAID · Research partner: UNIVERSITY OF NEVADA RENO
Antigen Detection Assay for the Diagnosis of Melioidosis
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $599,398
Solicitation PA11-097 (2012) · Topic NIAID · Research partner: UNIVERSITY OF NEVADA RENO
Sensitive and Specific Rapid Diagnostic Test for Acute and Chronic Pancreatitis
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $182,430
Solicitation PA11-096 (2012) · Topic NIDDK · Research partner: Stub
Development of Blood Donor Screening for Babesiosis
SBIR Phase I · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2012 · $149,437
Developing a Point-of-Care Diagnostic Assay for Leptospirosis
SBIR Phase II · Department of Defense (Army) · 2010 · $729,896
Oct 1, 2010 – Jul 3, 2013
Solicitation 2009.2 (2009) · Topic A09-105
Development of a hand-held, field-deployable multiplex assay for the detection of Chikungunya Virus (CHIKV), West Nile Virus (WNV), and Dengue Virus i
SBIR Phase I · Department of Defense (Army) · 2010 · $99,665
Mar 29, 2010 – Nov 14, 2010
Solicitation 2009.3 (2009) · Topic OSD09-H20
Development of a Point-of-care Assay for the Detection of Sand Fly Fever Virus (SFFV), a Militarily Important Pathogen of the CENTCOM, EUCOM and AFRIC
SBIR Phase II · Department of Defense (Army) · 2010 · $729,256
Nov 17, 2009 – Apr 1, 2012
Solicitation 2008.3 (2008) · Topic A08-182
Developing a Point-of-Care Diagnostic Assay for Leptospirosis
SBIR Phase I · Department of Defense (Army) · 2010 · $118,443
Nov 1, 2009 – Feb 3, 2011
Solicitation 2009.2 (2009) · Topic A09-105
Development of a Point-of-care Assay for the Detection of Rift Valley Fever Virus, a Militarily Important Pathogen of the CENTCOM and AFRICOM Area of
SBIR Phase I · Department of Defense (Army) · 2009 · $69,918
Feb 26, 2009 – Aug 25, 2009
Solicitation 2008.3 (2008) · Topic A08-180
A Point-of-Care Assay for the Detection of Coxiella Burnetii (Q fever) Infection in Soldiers Deployed to Iraq
SBIR Phase I · Department of Defense (Army) · 2009 · $69,456
Jan 23, 2009 – Aug 22, 2009
Solicitation 2008.3 (2008) · Topic A08-178
Development of a Point-of-care Assay for the Detection of Sand Fly Fever Virus (SFFV), a Militarily Important Pathogen of the CENTCOM, EUCOM and AFRIC
SBIR Phase I · Department of Defense (Army) · 2009 · $118,940
Jan 20, 2009 – Mar 1, 2010
Solicitation 2008.3 (2008) · Topic A08-182
Geographically robust rapid assay for T. cruzi infection
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2009 · $990,081
Solicitation PHS2009-2 (2009)
A Multiplexed Assay for the Detection of Pathogens of Military Importance in Sand Flies
SBIR Phase II · Department of Defense (Army) · 2008 · $729,960
Nov 17, 2008 – Nov 16, 2010
Solicitation 2007.2 (2007) · Topic A07-150
A Point-of-Care Assay for the Detection of Spotted-fever group and Typhus group Rickettsia.
SBIR Phase II · Department of Defense (Army) · 2008 · $1,209,590
Oct 9, 2008 – Dec 8, 2010
Solicitation 2007.2 (2007) · Topic A07-153
A Multiplexed Point-of-Care Assay for the Detection of Enteric Pathogens that Cause Severe Diarrhea in Deployed Soldiers
SBIR Phase II · Department of Defense (Army) · 2008 · $725,080
Oct 31, 2007 – Mar 31, 2011
Solicitation 2006.2 (2006) · Topic A06-158
A Point-of-Care Assay for the Detection of Spotted-fever group and Typhus group Rickettsia.
SBIR Phase I · Department of Defense (Army) · 2007 · $119,986
Oct 18, 2007 – Apr 17, 2008
Solicitation 2007.2 (2007) · Topic A07-153
A Multiplexed Assay for the Detection of Pathogens of Military Importance in Sand Flies
SBIR Phase I · Department of Defense (Army) · 2007 · $119,974
Oct 16, 2007 – Apr 15, 2008
Solicitation 2007.2 (2007) · Topic A07-150
Rapid antigen detection test for Dengue infection
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $375,019
Solicitation year 2007
Showing the 25 most recent of 41 awards.
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325413Title not in the curated listPrimary
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with INBIOS INTERNATIONAL INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
